A case of γ 1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy

Internal Medicine

Volumn 49, Issue 14, 2010, Pages 1411-1415

  Oe, Yuji ^a   Nakaya, Izaya ^a   Yahata, Mayumi ^a   Sakuma, Tsutomu ^a   Sato, Hiroshi ^b   Soma, Jun ^a  

^a Iwate Prefectural Central Hospital   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Heavy chain deposition disease; Melphalan; Prednisolone; Remission

Indexed keywords

ALBUMIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CREATININE; CYCLOSPORIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; MELPHALAN; PREDNISOLONE; PROTEIN;

AGED; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG RESPONSE; ELECTRON MICROSCOPY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HEAVY CHAIN DEPOSITION DISEASE; HEAVY CHAIN DISEASE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOCOMPLEMENTEMIA; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM; MULTIPLE CYCLE TREATMENT; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEINURIA; URINALYSIS;

AGED; DRUG THERAPY, COMBINATION; FEMALE; HEAVY CHAIN DISEASE; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; MELPHALAN; PREDNISOLONE;

EID: 77954987241     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3499     Document Type: Article

References (16)

1. Aucouturier P, Khamlichi AA, Touchard G, et al. Brief report: heavy-chain deposition disease. N Engl J Med 329: 1389-1393, 1993.
2. Moulin B, Deret S, Mariette X, et al. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking CH1. J Am Soc Nephrol 10: 519-528, 1999.
3. Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 12: 1482-1492, 2001.
4. Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P, D'agati VD. Heavy chain deposition disease: the disease spectrum. Am J Kidney Dis 33: 954-962, 1999.
5. Herzenberg AM, Lien J, Magil AB. Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case. Am J Kidney Dis 28: 128-131, 1996.
6. Soma J, Sato K, Sakuma T, et al. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia. Am J Kidney Dis 43: E10-E16, 2004.
7. Soma J, Tsuchiya Y, Sakuma T, Sato H. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma 3 heavy-chain deposition disease. Clin Nephrol 69: 383-386, 2008.
8. Tubbs RR, Berkley V, Valenzuela R, et al. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease. Mod Pathol 5: 185-190, 1992.
9. Herzenberg AM, Kiaii M, Magil AB. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG2 subtype. Am J Kidney Dis 35: E25, 2000.
10. Katz A, Zent R, Bargman JM. IgG heavy-chain deposition disease. Mod Pathol 7: 874-878, 1994.
11. Vedder AC, Weening JJ, Krediet RT. Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease. Nephrol Dial Transplant 19: 1302-1304, 2004.
12. Yasuda T, Fujita K, Imai H, Morita K, Nakamoto Y, Miura AB. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis. Clin Nephrol 44: 394-399, 1995.
13. Rott T, Vizjak A, Lindic J, Hvala A, Perkovic T, Cernelc P. IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle. Nephrol Dial Transplant 13: 1825-1828, 1998.
14. Parker CJ, Forester J. Mechanisms of immune destruction of erythrocytes. In: Wintrobe's Clinical Hematology. Pine JW Jr, Ed. Lippincott Williams & Wilkins, Philadelphia, 1996: 1191-1209.
15. Miletic VD, Frank MM. Complement-immunoglobulin interactions. Curr Opin Immunol 7: 41-47, 1995.
16. Komatsuda A, Maki N, Wakui H, et al. Development of systemic γ-light chain amyloidosis in a patient with γ-heavy chain deposition disease during long-term follow-up. Nephrol Dial Transplant 20: 434-437, 2005.